Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

for
Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative
Location: Chattanooga TN, Cincinnati OH, Columbus OH,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04468061

Phase2, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Nashville TN, Birmingham AL, Augusta GA, Chicago IL,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase1, Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

for
Epidermal Growth Factor, Epidermal Growth Factor Receptor,
Location: Nashville TN, Houston TX, East Brunswick NJ,
Sponsor: EpiBiologics

Sex: All

Age: 18+

Code: NCT07462377

Phase1, Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic,
Location: Nashville TN, Richmond VA, Saint Augustine FL,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05254743

Phase3, Recruiting

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

for
Plasma Cell Myeloma Refractory
Location: Nashville TN, Knoxville TN, Greenville SC,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06356571

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Denver CO, Nashville TN, St Louis MO, Chicago IL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase1, Recruiting

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

for
Solid Tumor, Adult, Solid Tumor, Melanoma, Basal Cell Cancer,
Location: Denver CO, Nashville TN
Sponsor: Rise Therapeutics LLC

Sex: All

Age: 18 - 70+

Code: NCT06398418

Phase1, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Nashville TN, Atlanta GA, St Louis MO, Durham NC,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase1, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumors
Location: Nashville TN, New Orleans LA, Orlando FL, Denver CO
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase1, Phase2, Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Nashville TN, Fairfax VA, Orlando FL, Dallas TX,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase1, Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Nashville TN, Cincinnati OH, Durham NC, Houston TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT03947385

Phase1, Phase2, Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Nashville TN, Atlanta GA, Orlando FL, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase1, Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Nashville TN, Indianapolis IN, St Louis MO, Columbus OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07046923

Phase1, Recruiting

A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

for
AML, MDS
Location: Nashville TN, Atlanta GA, Chapel Hill NC, Detroit MI,
Sponsor: TScan Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07702578

Phase3, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Nashville TN, Birmingham AL, St Louis MO,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase1, Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Nashville TN, Charlotte NC, Shreveport LA, Detroit MI,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase2, Recruiting

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Nashville TN, Birmingham AL, Atlanta GA, Charlotte NC,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT07116616

Phase1, Phase2, Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Nashville TN, Myrtle Beach SC, Cleveland OH,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07140900

Phase1, Recruiting

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

for
Advanced Solid Tumor
Location: Nashville TN, Scottsdale AZ
Sponsor: Strand Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07751042

Phase1, Phase2, Recruiting

A Study of CTD402 in T-ALL/LBL Patients

for
Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic
Location: Nashville TN, Chicago IL, Rochester MN, Houston TX,
Sponsor: Imviva Bio

Sex: All

Age: 1+

Code: NCT07070219

Phase1, Phase2, Recruiting